Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

United Therapeutics Corporation (UTHR)

  • Business News
  • Dec. 19, 2025, 21:40 UTC
  • 10
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

PTC Therapeutics Inc (PTCT)

  • Business News
  • Dec. 19, 2025, 21:30 UTC
  • 5
  • 1 comments

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Ultragenyx Pharmaceutical Inc (RARE)

  • Business News
  • Dec. 19, 2025, 21:30 UTC
  • 6
  • 1 comments

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Medtronic plc. (MDT)

  • Business News
  • Dec. 19, 2025, 21:20 UTC
  • 5
  • 1 comments

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

Market reaction Comment Full text

Inovio Pharmaceuticals Inc (INO)

  • Business News
  • Dec. 19, 2025, 21:06 UTC
  • 5
  • 1 comments

Inovio - INOVIO Reports Inducement Grant Under Inducement Plan

Market reaction Comment Full text

Inovio Pharmaceuticals Inc (INO)

  • Business News
  • Dec. 19, 2025, 21:05 UTC
  • 13
  • 1 comments

INOVIO Reports Inducement Grant Under Inducement Plan

Market reaction Comment Full text

Rewalk Robotics Ltd (LFWD)

  • Business News
  • Dec. 19, 2025, 21:05 UTC
  • 11
  • 1 comments

Lifeward Appoints Bob Marshall as Chairman of the Board

Market reaction Comment Full text

Pulse Biosciences Inc (PLSE)

  • Business News
  • Dec. 19, 2025, 21:05 UTC
  • 7
  • 1 comments

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Aclaris Therapeutics Inc (ACRS)

  • Business News
  • Dec. 19, 2025, 21:01 UTC
  • 6
  • 1 comments

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)

Market reaction Comment Full text

Cytokinetics Inc (CYTK)

  • Business News
  • Dec. 19, 2025, 21:00 UTC
  • 5
  • 1 comments

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

Market reaction Comment Full text
  • Previous
  • 266
  • 267
  • 268
  • 269
  • 270
  • Next

Search

News categories

  • Technical Exchange News(10896)
  • Event(2296)
  • SEC News(190041)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124780)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin